Catheter ablation of atrial fibrillation in patients with diabetes mellitus

Catheter ablation of atrial fibrillation in patients with diabetes mellitus

Background: Diabetes mellitus (DM) is an independent risk factor for atrial fibrillation (AF). Few studies have compared clinical outcomes after catheter ablation between patients with and those without DM. Objective: The purpose of this study was to compare AF ablation outcomes in patients with and...

Full description

Bibliographic Details
Main Authors:	Allen Wang, MD, Tracy Truong, MB, Eric Black-Maier, MD, Cynthia Green, PhD, Kristen B. Campbell, PharmD, Adam S. Barnett, MD, Janice Febre, BSN, RN, Zak Loring, MD, MHS, Sana M. Al-Khatib, MD, MHS, FHRS, Brett D. Atwater, MD, James P. Daubert, MD, FHRS, Camille Frazier-Mills, MD, MHS, Donald D. Hegland, MD, Kevin P. Jackson, MD, Larry R. Jackson, MD, Jason I. Koontz, MD, PhD, Robert K. Lewis, MD, PhD, Sean D. Pokorney, MD, MBA, Albert Y. Sun, MD, Kevin L. Thomas, MD, Tristam D. Bahnson, MD, FHRS, Jonathan P. Piccini, MD, MHS, FHRS
Format:	Article
Language:	English
Published:	Elsevier 2020-08-01
Series:	Heart Rhythm O2
Subjects:	Atrial fibrillation Catheter ablation Diabetes mellitus Glycemic control Outcomes
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666501820300386

Similar Items

High-density mapping of the tachycardia circuit in atrioventricular nodal reentrant tachycardia
by: Benjamin A. Steinberg, MD, MHS, et al.
Published: (2016-09-01)

Noninvasive electrocardiographic mapping of ventricular tachycardia in a patient with a left ventricular assist device
by: Michael R. Rehorn, MD, MS, et al.
Published: (2020-07-01)

Changes in the digital health landscape in cardiac electrophysiology: A pre-and peri-pandemic COVID-19 era survey
by: Janet K. Han, MD, FHRS, et al.
Published: (2021-02-01)

HRS White Paper on Clinical Utilization of Digital Health Technology
by: Elaine Y. Wan, MD, FHRS, et al.
Published: (2021-08-01)

Prolonged high-power endocardial ablation of epicardial microreentrant VT from the LV summit in a patient with nonischemic cardiomyopathy
by: Jorge Romero, MD, et al.
Published: (2015-11-01)

Simultaneous atrioventricular node ablation and leadless pacemaker implantation
by: Jeffrey Ho, MD, et al.
Published: (2017-03-01)

Fibrous encapsulation of defibrillation electrode and elevated high-voltage impedance in patients with a subcutaneous implantable cardioverter-defibrillator
by: Jian-Ming Li, MD, PhD, FHRS, et al.
Published: (2020-03-01)

Air emboli during the procedure of transcatheter left atrial appendage closure
by: Shuang Li, MD, et al.
Published: (2016-11-01)

Orthostatic increase in defibrillation threshold leading to defibrillation failure and prolonged cardiac arrest in a sitting position: Lessons from a patient’s near-fatal experience
by: Xiaoke Liu, MD, PhD, et al.
Published: (2016-07-01)

Sex differences in left ventricular electrical dyssynchrony and outcomes with cardiac resynchronization therapy
by: Daniel J. Friedman, MD, et al.
Published: (2020-10-01)

Digital health in electrophysiology and the COVID-19 global pandemic
by: David J. Slotwiner, MD, FHRS, FACC, et al.
Published: (2020-12-01)

Atrioventricular junctional ablation: The good, the bad, the better
by: Benjamin J. Scherlag, PhD, FHRS, et al.
Published: (2020-10-01)

Peri–coronary sinus atrial flutter associated with prior slow pathway ablation
by: Mitsunori Maruyama, MD, PhD, FHRS, et al.
Published: (2018-01-01)

Brugada syndrome—Malignant phenotype associated with acute cardiac inflammation?
by: Anthony Li, MBBS, MD, et al.
Published: (2017-08-01)

Emerging role of artificial intelligence in cardiac electrophysiology
by: Rajesh Kabra, MD, FHRS, et al.
Published: (2022-12-01)

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
by: Bruce L. Wilkoff, MD, FHRS, CCDS, et al.
Published: (2016-02-01)

Catheter ablation and healthcare utilization and cost among patients with paroxysmal versus persistent atrial fibrillation
by: Daniel J. Friedman, MD, et al.
Published: (2021-02-01)

Third-degree burns caused by transcutaneous pacing for third-degree heart block
by: Matthew J. Singleton, MD, MBE, MHS, MSc, FIT-HRS, et al.
Published: (2020-08-01)

Physical activity, patient-reported symptoms, and clinical events: Insights into postprocedural recovery from personal digital devices
by: Victoria L. Bartlett, BA, et al.
Published: (2021-08-01)

Safe and effective delivery of high-power, short-duration radiofrequency ablation lesions with a flexible-tip ablation catheter
by: Leon M. Ptaszek, MD, PhD, FHRS, et al.
Published: (2023-01-01)

Risk of atrioesophageal fistula with cryoballoon ablation of atrial fibrillation
by: Jonathan P. Piccini, MD, MHS, FHRS, et al.
Published: (2020-08-01)

Unregulated online sales of cardiac implantable electronic devices in the United States: A six-month assessment
by: Bolanle Akinyele, MD, et al.
Published: (2020-10-01)

Transmural conduction delay and block producing a pseudo-infarction electrocardiogram during treatment of anaphylaxis
by: Matthew Olson, MD, et al.
Published: (2022-06-01)

Right ventricular lead proarrhythmia: A novel intervention for an under-recognized phenomenon
by: Justin Hayase, MD, et al.
Published: (2018-02-01)

Erratum to ‘2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-deﬁbrillator programming and testing’ [Journal of Arrhythmia 32/1 (2016) 1–28]
by: Bruce L. Wilkoff, MD, FHRS, CCDS, et al.
Published: (2016-10-01)

Patients with hemophilia: Unique challenges for atrial fibrillation management
by: Jeffrey Y. Lin, MD, et al.
Published: (2015-11-01)

Inappropriate shocks in a patient with a subcutaneous implantable cardioverter-defibrillator
by: Sana M. Al-Khatib, MD, MHS, FHRS, et al.
Published: (2016-11-01)

When smartwatches contribute to health anxiety in patients with atrial fibrillation
by: Lindsey Rosman, PhD, et al.
Published: (2020-07-01)

Wide-area antral pulmonary vein and posterior wall isolation by way of segmental nonocclusive applications using a novel radiofrequency ablation balloon
by: Arash Aryana, MD, PhD, FHRS, et al.
Published: (2021-08-01)

Exercise-induced arrhythmogenic right ventricular cardiomyopathy: Reverse remodeling with detraining
by: Douglas Darden, MD, et al.
Published: (2022-09-01)

Cardioneuroablation: Where are we at?
by: Jose Carlos Pachon, PhD, MD, FHRS, et al.
Published: (2023-06-01)

Combination of a leadless pacemaker and subcutaneous defibrillator: First in-human report
by: Blandine Mondésert, MD, et al.
Published: (2015-11-01)

Impact of low-level electromagnetic fields on the inducibility of atrial fibrillation in the electrophysiology laboratory
by: Daniel Sohinki, MD, MSc, FACC, FHRS, et al.
Published: (2021-06-01)

Suppression of sleep syncope and vagally-mediated asystole by norepinephrine transporter inhibitor
by: Alessandra Rabajoli, MD, et al.
Published: (2024-09-01)

Safety and feasibility of radiofrequency redo pulmonary vein isolation ablation for atrial fibrillation after Amulet implantation and device electrical characteristics
by: Grzegorz M. Pietrasik, MD, PhD, et al.
Published: (2020-07-01)

Should Catheter Ablation Be Indicated Only for Symptom-Relief of AF?
by: Yoshito Iesaka, MD PhD FHRS
Published: (2011-01-01)

Lengthening the atrioventricular delay reduces large left atrial v waves and dyspnea after atrial fibrillation and tachycardia ablation
by: Raman Mitra, MD, PhD, FHRS
Published: (2017-12-01)

Options for ventricular tachycardia ablation after double valve replacement
by: Samuel H. Baldinger, MD, et al.
Published: (2015-07-01)

Safety and acute efficacy of catheter ablation for atrial fibrillation with pulsed field ablation vs thermal energy ablation: A meta-analysis of single proportions
by: Omar M. Aldaas, MD, et al.
Published: (2023-10-01)

Atrial fibrillation associated with Wolff-Parkinson-White syndrome in a patient with concomitant Brugada syndrome
by: Shaobo Shi, MD, PhD, et al.
Published: (2017-01-01)